Choosing and using HIV prevention (PrEP) that fits you
RFA-PS-21-003: PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices
['FUNDING_U01'] · FLORIDA STATE UNIVERSITY · NIH-11128323
This project tries ways to help people at risk for HIV pick the right PrEP option and stay on it to reduce their chance of getting HIV.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FLORIDA STATE UNIVERSITY (nih funded) |
| Locations | 1 site (TALLAHASSEE, UNITED STATES) |
| Trial ID | NIH-11128323 on ClinicalTrials.gov |
What this research studies
You would be offered clear information and choices about PrEP — such as daily pills or newer long-acting options — plus support to help you decide what fits your life. The research team will partner with clinics and community groups to provide counseling, decision tools, and navigation services. They will follow participants over time to see which approaches lead to more people starting and continuing PrEP. The aim is to identify straightforward, clinic-ready methods to help more people stay protected from HIV.
Who could benefit from this research
Good fit: Ideal participants are people at risk for HIV who are interested in prevention options — for example, those with recent condomless sex, partners with HIV, men who have sex with men, transgender people, or people who inject drugs.
Not a fit: People who are not at risk for HIV, already stably using an effective prevention method, or unable to attend clinic visits are less likely to benefit.
Why it matters
Potential benefit: If successful, more people at risk could start and keep using PrEP, lowering new HIV infections.
How similar studies have performed: Previous programs offering navigation, counseling, and outreach have increased PrEP starts, and long-acting injectable PrEP has shown efficacy, but real-world strategies for offering choice and sustaining use are still being refined.
Where this research is happening
TALLAHASSEE, UNITED STATES
- FLORIDA STATE UNIVERSITY — TALLAHASSEE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HIGHTOW-WEIDMAN, LISA B — FLORIDA STATE UNIVERSITY
- Study coordinator: HIGHTOW-WEIDMAN, LISA B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.